Mark A. Frye, MD

Original Research

Supraphysiologic Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression: A Randomized, Double-Blind, Placebo-Controlled Study

November 26, 2013

Thomas J. Stamm, Ute Lewitzka, Cathrin Sauer, et al

Commentary

Paradigm Shift: Preliminary Clinical Categorization of Ultrahigh Risk for Childhood Bipolar Disorder to Facilitate Studies on Prevention

February 15, 2013

Robert M. Post, Kiki Chang, Mark A. Frye

Original Research

Relationship of Prior Antidepressant Exposure to Long-Term Prospective Outcome in Bipolar I Disorder Outpatients

March 20, 2012

Robert M. Post, Gabriele S. Leverich, Lori L. Altshuler, et al

Article

International Consensus Group on Depression Prevention in Bipolar Disorder

October 24, 2011

Mark A. Frye, Kyooseob Ha, Shigenobu Kanba, et al

Original Research

Complexity of Pharmacologic Treatment Required for Sustained Improvement in Outpatients With Bipolar Disorder

September 15, 2010

Robert M. Post, Lori L. Altshuler, Mark A. Frye, et al

Original Research

Adjunctive Armodafinil for Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Proof-of-Concept Study

July 27, 2010

Joseph R. Calabrese, Terence A. Ketter, James M. Youakim, et al

Original Research

Early-Onset Bipolar Age & Treatment Delay

July 15, 2010

Read an article examining the influence of age at early onset bipolar disorder and the delay in time to first treatment on morbidity in adulthood.

Robert M. Post, Gabriele S. Leverich, Ralph W. Kupka, et al

Original Research

Olanzapine/Fluoxetine Combination for the Treatment of Mixed Depression in Bipolar I Disorder: A Post Hoc Analysis

October 15, 2009

Franco Benazzi, Michael Berk, Mark A. Frye, et al

Original Research

Mood Stabilization and Destabilization During Acute and Continuation Phase Treatment for Bipolar I Disorder With Lamotrigine or Placebo

August 11, 2009

Joseph F. Goldberg, Joseph R. Calabrese, Benjamin R. Saville, et al

Original Research

Impact of Antidepressant Continuation After Acute Positive or Partial Treatment Response for Bipolar Depression: A Blinded, Randomized Study

April 7, 2009

Lori L. Altshuler, Robert M. Post, Gerhard Hellemann, et al

Educational Activity

Diagnostic Dilemmas and Clinical Correlates of Mixed States in Bipolar Disorder

May 11, 2008

Mark A. Frye

Academic Highlights

Diagnosis and Treatment Strategies for Mixed Episodes in Bipolar Disorder

December 14, 2007

Susan L. McElroy, Mark A. Frye, Joseph F. Goldberg, et al

Supraphysiologic Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression: A Randomized, Double-Blind, Placebo-Controlled Study

Paradigm Shift: Preliminary Clinical Categorization of Ultrahigh Risk for Childhood Bipolar Disorder to Facilitate Studies on Prevention

Relationship of Prior Antidepressant Exposure to Long-Term Prospective Outcome in Bipolar I Disorder Outpatients

International Consensus Group on Depression Prevention in Bipolar Disorder

Complexity of Pharmacologic Treatment Required for Sustained Improvement in Outpatients With Bipolar Disorder

Adjunctive Armodafinil for Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Proof-of-Concept Study

Early-Onset Bipolar Age & Treatment Delay

Olanzapine/Fluoxetine Combination for the Treatment of Mixed Depression in Bipolar I Disorder: A Post Hoc Analysis

Mood Stabilization and Destabilization During Acute and Continuation Phase Treatment for Bipolar I Disorder With Lamotrigine or Placebo

Impact of Antidepressant Continuation After Acute Positive or Partial Treatment Response for Bipolar Depression: A Blinded, Randomized Study

Diagnostic Dilemmas and Clinical Correlates of Mixed States in Bipolar Disorder

Diagnosis and Treatment Strategies for Mixed Episodes in Bipolar Disorder

ELSEWHERE:

FOLLOW US:

Mark A. Frye, MD

Supraphysiologic Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression: A Randomized, Double-Blind, Placebo-Controlled Study

Paradigm Shift: Preliminary Clinical Categorization of Ultrahigh Risk for Childhood Bipolar Disorder to Facilitate Studies on Prevention

Relationship of Prior Antidepressant Exposure to Long-Term Prospective Outcome in Bipolar I Disorder Outpatients

International Consensus Group on Depression Prevention in Bipolar Disorder

Complexity of Pharmacologic Treatment Required for Sustained Improvement in Outpatients With Bipolar Disorder

Adjunctive Armodafinil for Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Proof-of-Concept Study

Early-Onset Bipolar Age & Treatment Delay

Olanzapine/Fluoxetine Combination for the Treatment of Mixed Depression in Bipolar I Disorder: A Post Hoc Analysis

Mood Stabilization and Destabilization During Acute and Continuation Phase Treatment for Bipolar I Disorder With Lamotrigine or Placebo

Impact of Antidepressant Continuation After Acute Positive or Partial Treatment Response for Bipolar Depression: A Blinded, Randomized Study

Diagnostic Dilemmas and Clinical Correlates of Mixed States in Bipolar Disorder

Diagnosis and Treatment Strategies for Mixed Episodes in Bipolar Disorder

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles